先端医療ベンチャー(週刊東洋経済ｅビジネス新書Ｎo.309)
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
New to Audible Prime Member exclusive: 2 credits with free trial
1 credit a month to use on any title to download and keep
Listen to anything from the Plus Catalogue—thousands of Audible Originals, podcasts and audiobooks
Download titles to your library and listen offline
₹199 per month after 30-day trial. Cancel anytime.
先端医療ベンチャー(週刊東洋経済ｅビジネス新書Ｎo.309)
Narrated by:
海老塚 久蔵
Buy Now for ₹279.00
No valid payment method on file.
We are sorry. We are not allowed to sell this product with the selected payment method
Pay using card ending in
By confirming your purchase, you agree to Audible's Conditions of Use and Amazon's Privacy Notice.
-
Narrated by:
-
海老塚 久蔵
-
Written by:
-
週刊東洋経済編集部
About this listen
２０１８年、世界のベンチャーキャピタルによるバイオテクノロジー分野への投資額は約１・７兆円に達し、１０年で７倍近くに膨らんだ。ゲノム解読費用が急減し、ビッグデータの活用で、患者一人ひとりに合わせた医療を提供する「プレシジョン・メディシン」の到来だ。製薬業界でもバイオベンチャーが開発した遺伝子治療薬やウイルス製剤などが希少疾患で成果を上げ、Ｍ＆Ａや提携も活発化している。次世代における医療の覇者は誰か。最先端ベンチャーを通して、未来をのぞく。
本誌は『週刊東洋経済』２０１９年４月２０日号掲載の２６ページ分を電子化したものです。©東洋経済新報社 (P)2020 Audible, Inc.